Prelude Therapeutics Inc
PRLD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001678660
No open-market purchases or sales by Prelude Therapeutics Inc insiders were filed in the last 90 days; 75 institutions reported holding it in 13F filings for Q2 2026, worth $264.3M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Prelude Therapeutics Inc changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 55 | 60 | +5 |
| Shares | 38.5M | 36.6M | −1.93M (−5.0%) |
| Value | $176.2M | $113.1M | −$63.1M (−35.8%) |
New holders (7)
Institutions that held Prelude Therapeutics Inc at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sio Capital Management, LLC | 350,000 | $1.08M | 0.33% |
| Pale Fire Capital SE | 30,781 | $95.1K | 0.01% |
| HSBC Holdings PLC | 23,198 | $70.8K | 0.00% |
| Acadian Asset Management LLC | 7,023 | $21.0K | 0.00% |
| Allspring Global Investments Holdings, LLC | 6,107 | $18.9K | 0.00% |
| Deutsche Bank AG | 446 | $1.38K | 0.00% |
| Simplex Trading, LLC | 31 | $0 | 0.00% |
Sold out (2)
Institutions that held Prelude Therapeutics Inc at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| UBS Asset Management Americas Inc | 2,273,894 | $13.0M |
| Mirae Asset Global Investments Co., Ltd. | 10,087 | $45.4K |